- Establishing innovative multi-disciplinary partnerships
- Fostering new technologies
- Moving medicine forward
Stanford University has been selected as a partner
by the Wallace
H. Coulter Foundation, which supports collaborative translational
research projects through an award to Bioengineering, one of nine
such awards nationwide.
The Stanford-Coulter Translational Research Grants Program awards
$800,000 a year to Bioengineering faculty members and their clinician
researcher collaborators from the School of Medicine. Together,
these teams of co-investigators work to develop new technologies
that address unmet clinical needs, improve health care and lead
to commercially available products.
Stanford University brings together top-notch clinical research and a tradition of innovation on its campus in the heart of Silicon Valley, the technology capital of the world. This unique position, along with support from the Coulter foundation, will allow awardees to quickly and expertly meet the challenges and needs facing medicine today.
Learn about the grant
and the application process>> |
|
 |
|
Translational
bioengineering is almost a redundant idea, because the goal of
bioengineering is specifically to discover and invent in order
to impact the world! Read more>> |
 |
|
Minimally
invasive high-speed imaging of sarcomere
contractile dynamics
This project
has allowed direct visualization of individual sarcomeres and
their dynamical length variations using minimally invasive
optical microendoscopy.
Read Nature paper (pdf)
|
 |
|
Five research
teams that will use bioengineering methods to tackle clinical
problems have received a total of $432,000 in seed grant funds
from the Wallace H. Coulter Translational Research Grant Program.
The five projects receiving the 2011 grants are:
- Rapid viral identification device using nanochannel FET
detectors — Annelise Barron, PhD, associate professor of
bioengineering, and Michael Snyder, MD, professor of genetics.
- Fast, pinhole camera-phone based imaging of oral cavity
for early cancer detection — Manu Prakash, PhD, acting assistant
professor of bioengineering, and Michael Clarke, MD, professor
of oncology.
- A novel solution for temporary cardiac pacing — Jeffrey
Feinstein, MD, associate professor of bioengineering and
of pediatric cardiology, and Paul Wang, MD, professor of
cardiovascular medicine.
- Portable respiratory acoustic monitoring device — Thomas
Krummel, MD, professor of surgery and of bioengineering,
and Paul Sharek, MD, associate professor of pediatrics.
- Minimally invasive creation of autologous venous valves
for the treatment of deep venous insufficiency — Paul Yock,
MD, professor of bioengineering and of medicine, and Jason
Lee, MD, assistant professor of surgery.
|
|